文献速递呼吸衰竭与机械通气重症综合管理与镇静镇痛

急性呼吸窘迫综合征中两种基于跨肺压的呼气末正压滴定策略比较:一项随机交叉研究

Comparison of two transpulmonary pressure-based positive end-expiratory pressure titration strategies in acute respiratory distress syndrome: a randomized crossover study.
PubMed 文献 · Crit Care · 2025-09-29
一句话结论两种基于跨肺压的PEEP滴定策略在中重度ARDS患者中所得PEEP中位数无差异但个体值不相关,70%患者相差至少3 cmH2O,且对气体交换、血流动力学及呼吸力学的影响无差异。

本研究为随机交叉生理学研究,纳入20例中重度ARDS(PaO2/FiO2 < 150 mmHg)患者,在学术型ICU中比较两种基于跨肺压的PEEP滴定策略:直接测量的呼气末跨肺压(PL, exp)策略和计算得出的吸气末跨肺压(PL, insp)策略,每种策略应用45分钟,间隔45分钟洗脱期。结果显示两种策略确定的PEEP中位数无差异,但个体值不相关,14例(70%)患者PEEP相差至少3 cmH2O;在非肥胖患者中PL, insp策略所得PEEP高于PL, exp策略,肥胖患者中无此差异。两种策略对气体交换、血流动力学、呼吸力学、PEEP复张肺容积、跨肺驱动压及肺应变的影响均无差异。结论认为两种策略在多数患者中产生不同PEEP水平,但均未带来更高的复张肺容积或更低的预估应力和应变。

要点

  • 在20例中重度ARDS(PaO2/FiO2 < 150 mmHg)患者中,两种跨肺压PEEP滴定策略所得PEEP中位数无差异,但个体值不相关,14例(70%)患者相差至少3 cmH2O。
  • 非肥胖患者中PL, insp策略所得PEEP高于PL, exp策略,肥胖患者中两种策略所得PEEP无差异。
  • 两种策略对气体交换、血流动力学、呼吸力学、PEEP复张肺容积、跨肺驱动压及肺应变的影响在整个研究人群及肥胖/非肥胖亚组中均无差异。
  • 作者结论认为两种策略在多数患者中产生不同PEEP水平,但均未带来更高的复张肺容积或更低的预估应力和应变。

适用人群与场景

  • 纳入中重度ARDS患者,PaO2/FiO2 < 150 mmHg,共20例,在学术型ICU中研究。

诊断标准与关键阈值

  • 中重度ARDS定义:PaO2/FiO2 < 150 mmHg。
  • PL, insp策略目标:通过肺/呼吸系统弹性比值估算的吸气末跨肺压维持在20至22 cmH2O之间。

处置流程与药物剂量

  • PL, exp策略:使用PL, exp/FiO2表格设定PEEP以目标呼气末跨肺压。
  • PL, insp策略:设定PEEP以维持通过肺/呼吸系统弹性比值估算的吸气末跨肺压在20至22 cmH2O。
  • 两种策略各应用45分钟,随机顺序,间隔45分钟洗脱期。

研究设计与关键结果

  • 研究类型:随机交叉生理学研究;样本量20例;单中心(学术型ICU);人群:中重度ARDS(PaO2/FiO2 < 150 mmHg)。
  • 干预:两种基于跨肺压的PEEP滴定策略(PL, exp策略 vs PL, insp策略),各45分钟,洗脱45分钟。
  • 主要终点结果:两种策略所得PEEP中位数无差异;个体值不相关,14例(70%)患者PEEP相差至少3 cmH2O。
  • 关键次要终点:非肥胖患者中PL, insp策略所得PEEP高于PL, exp策略,肥胖患者中无差异;气体交换、血流动力学、呼吸力学、PEEP复张肺容积、跨肺驱动压及肺应变在两种策略间无差异(整个研究人群及肥胖/非肥胖亚组)。

证据类型、等级与局限

  • 证据类型:随机交叉生理学研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者结论认为两种跨肺压PEEP滴定策略在多数患者中产生不同PEEP水平,但均未带来更高的复张肺容积或更低的预估应力和应变。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Esophageal pressure monitoring, which enables the estimation of transpulmonary pressure, has been proposed to personalize ventilator settings, particularly positive end-expiratory pressure (PEEP), in patients with acute respiratory distress syndrome (ARDS). Two conceptually different transpulmonary pressure-based PEEP titration strategies have thus been described but have never been compared. This study aims to compare the PEEP levels obtained with these two distinct strategies and their physiological effects.

METHODS: This was a randomized crossover physiological study. Twenty patients with moderate to severe ARDS (PaO2/FiO2 < 150 mmHg) were included in an academic intensive care unit. The two transpulmonary pressure-based PEEP titration strategies were applied for 45 min each in a randomized order, separated by a 45-minute washout period. In the directly measured expiratory transpulmonary pressure (PL, exp) strategy, PEEP was set to target a PL, exp using a PL, exp/FiO2 table. In the calculated inspiratory transpulmonary pressure (PL, insp) strategy, PEEP was set to maintain PL, insp estimated using the lung/respiratory system elastance ratio between 20 and 22 cmH2O. Gas exchange, hemodynamics and partitioned respiratory mechanics were assessed at the end of each PEEP application period.

RESULTS: Median PEEP levels determined by the two strategies were not different; however, individual values were uncorrelated, with a difference of at least 3 cmH2O in 14 (70%) patients. The PL, insp strategy resulted in higher PEEP levels than the PL, exp strategy in the non-obese patients but not in the obese patients. The effects on gas exchange, hemodynamics, and respiratory mechanics did not differ between the two strategies considering the entire study population or the obese and non-obese patients separately. Recruitment with PEEP (assessed by the recruited lung volume from PEEP 5 cmH2O), PL, insp, transpulmonary driving pressure and lung strain did not differ between the two strategies.

CONCLUSIONS: The two transpulmonary pressure-based titration strategies result in different PEEP levels in most patients. Neither strategy is associated with higher recruited lung volume or lower estimated Stress and Strain.

TRIAL REGISTRATION: #NCT03281473 Clinicaltrials.gov. Registered 12 September 2017.

来源:Crit Care,查看原文。版权归原作者所有。

参考来源

  1. Chean D, Courtais A, Pavlovsky B, et al. Comparison of two transpulmonary pressure-based positive end-expiratory pressure titration strategies in acute respiratory distress syndrome: a randomized crossover study. Crit Care. 2025. PMID: 41024114. doi:10.1186/s13054-025-05626-x

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。